Clinical trial
Antialbuminuric Effects of Valsartan and Lisinopril
NCT00171600 · Novartis, Industry · Terminated
Key facts
| NCT number | NCT00171600 |
|---|---|
| Title | Antialbuminuric Effects of Valsartan and Lisinopril |
| Official title | Comparative, Open Multicenter Trial Assessing the Effect on Albumin Excretion Rate of 320mg Valsartan (With or Without HCTZ) vs 40mg Lisinopril (With or Without HCTZ) on Hypertensive Patients With Diabetic and Non-diabetic Nephropathy and Albuminuria |
| Lead sponsor | Novartis, Industry |
| Status | Terminated |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hypertension, Early Diabetic Nephropathy |
| Intervention type | Drug |
| Interventions | VALSARTAN, VALSARTAN PLUS HCTZ, LISINOPRIL, LISINOPRIL PLUS HCTZ |
| Enrollment | 54 |
| Start date | Jul 1, 2005 |
| Primary completion | Jan 1, 2007 |
| Completion | Jan 1, 2007 |
| First posted | Sep 15, 2005 |
| Last update posted | Nov 8, 2011 |
| Countries | Switzerland |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: